• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Sarvikas Juho was granted 124,347 shares (SEC Form 4)

    1/7/25 4:47:14 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications
    Get the next $INSG alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sarvikas Juho

    (Last) (First) (Middle)
    9710 SCRANTON ROAD
    SUITE 200

    (Street)
    SAN DIEGO CA 92121

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    INSEEGO CORP. [ INSG ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    01/06/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/06/2025 A 124,347 A(1) $0 123,347 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Options (right to buy) $10.72 01/06/2025 A 200,000 (2) 01/06/2035 Common Stock 200,000 $0 200,000 D
    Stock Options (right to buy) $15.72 01/06/2025 A 210,000 (2) 01/06/2035 Common Stock 210,000 $0 210,000 D
    Stock Options (right to buy) $20.72 01/06/2025 A 215,000 (2) 01/06/2035 Common Stock 215,000 $0 215,000 D
    Stock Options (right to buy) $25.72 01/06/2025 A 225,000 (2) 01/06/2035 Common Stock 225,000 $0 225,000 D
    Performance Share Units $0 01/06/2025 A 167,910 (3) (3) Common Stock 167,910 $0 167,910 D
    Explanation of Responses:
    1. Represents restricted stock units scheduled to vest over a four-year period, with one-fourth vesting on the first anniversary of the grant date and 1/48th vesting monthly thereafter through the fourth anniversary of the grant date.
    2. Twenty-five percent (25%) of the shares subject to the Options shall be first eligible to vest and become exercisable on the first anniversary of the grant date and (b) 1/48 of the shares vest on each monthly anniversary thereafter (such Options which have become so eligible, "Eligible Options"), such that one hundred percent (100%) of the Options shall become Eligible Options on the four-year anniversary of the Grant Date. The Options shall vest and become only if (a) they have become Eligible Options; and (b) the average of the per-share closing price of the Company's common stock as reported on the principal exchange on which the shares are listed has equaled or exceeded the exercise price for twenty (20) trading days within any 30-day period prior to the date of exercise.
    3. Represents target award of performance restricted stock units that will be earned and vest based upon on the performance of the Company's Common Stock relative to the total shareholder return of Russell Microcap Index ("rTSR") between January 6, 2025 and January 7, 2028 (the "Performance Period"). The number of shares that will be issued will be between zero and 200% of the target award, depending on the level of performance through the Performance Period.
    /s/ Kurt E. Scheuerman, Attorney-in-Fact 01/06/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $INSG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INSG

    DatePrice TargetRatingAnalyst
    11/14/2024$13.00 → $15.00Neutral → Buy
    ROTH MKM
    5/13/2022$2.50Hold
    Stifel
    3/2/2022$8.00 → $7.00Hold → Buy
    Canaccord Genuity
    8/5/2021$8.50 → $7.50Neutral
    Roth Capital
    More analyst ratings